Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Susceptibility to Bladder Cancer: A Molecular Epidemiology Approach

NCT00848289 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00848289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00848289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Susceptibility to Bladder Cancer: A Molecular Epidemiology Approach
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
February 10, 1998
Completion date
August 1, 2026
Enrollment
6,086 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer